A citation-based method for searching scientific literature

Subhajit Poddar, Jennifer L Hyde, Matthew J Gorman, Michael Farzan, Michael S Diamond. J Virol 2016
Times Cited: 47







List of co-cited articles
395 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
505
51

The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
Matthew J Gorman, Subhajit Poddar, Michael Farzan, Michael S Diamond. J Virol 2016
59
51

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
879
51

Ifitm3 limits the severity of acute influenza in mice.
Charles C Bailey, I-Chueh Huang, Christina Kam, Michael Farzan. PLoS Pathog 2012
158
38

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
401
38

The IFITMs Inhibit Zika Virus Replication.
George Savidis, Jill M Perreira, Jocelyn M Portmann, Paul Meraner, Zhiru Guo, Sharone Green, Abraham L Brass. Cell Rep 2016
136
38

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
Eric M Feeley, Jennifer S Sims, Sinu P John, Christopher R Chin, Thomas Pertel, Li-Mei Chen, Gaurav D Gaiha, Bethany J Ryan, Ruben O Donis, Stephen J Elledge,[...]. PLoS Pathog 2011
258
36

IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
149
34

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
222
34

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
187
34

A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
31

The IFITM proteins inhibit HIV-1 infection.
Jennifer Lu, Qinghua Pan, Liwei Rong, Wei He, Shan-Lu Liu, Chen Liang. J Virol 2011
272
31

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.
Charles C Bailey, Guocai Zhong, I-Chueh Huang, Michael Farzan. Annu Rev Virol 2014
245
31


The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.
Sumudu K Narayana, Karla J Helbig, Erin M McCartney, Nicholas S Eyre, Rowena A Bull, Auda Eltahla, Andrew R Lloyd, Michael R Beard. J Biol Chem 2015
76
31

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
121
29

Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.
Jacob S Yount, Bruno Moltedo, Yu-Ying Yang, Guillaume Charron, Thomas M Moran, Carolina B López, Howard C Hang. Nat Chem Biol 2010
253
29

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
Alex A Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob S Yount, Chen Liang, Olivier Schwartz. EMBO Rep 2016
63
29

Alphavirus Restriction by IFITM Proteins.
Stuart Weston, Stephanie Czieso, Ian J White, Sarah E Smith, Rachael S Wash, Carmen Diaz-Soria, Paul Kellam, Mark Marsh. Traffic 2016
26
53

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
Rui Jia, Qinghua Pan, Shilei Ding, Liwei Rong, Shan-Lu Liu, Yunqi Geng, Wentao Qiao, Chen Liang. J Virol 2012
121
27

Identification of an endocytic signal essential for the antiviral action of IFITM3.
Rui Jia, Fengwen Xu, Jin Qian, Yunfang Yao, Chunhui Miao, Yi-Min Zheng, Shan-Lu Liu, Fei Guo, Yunqi Geng, Wentao Qiao,[...]. Cell Microbiol 2014
86
27

Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.
Tsai-Yu Lin, Christopher R Chin, Aaron R Everitt, Simon Clare, Jill M Perreira, George Savidis, Aaron M Aker, Sinu P John, David Sarlah, Erick M Carreira,[...]. Cell Rep 2013
72
27

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Samad Amini-Bavil-Olyaee, Youn Jung Choi, Jun Han Lee, Mude Shi, I-Chueh Huang, Michael Farzan, Jae U Jung. Cell Host Microbe 2013
215
25

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
124
25


The broad-spectrum antiviral functions of IFIT and IFITM proteins.
Michael S Diamond, Michael Farzan. Nat Rev Immunol 2013
453
23

IFITM proteins-cellular inhibitors of viral entry.
Se Smith, S Weston, P Kellam, M Marsh. Curr Opin Virol 2014
80
23

IFITM3 requires an amphipathic helix for antiviral activity.
Nicholas M Chesarino, Alex A Compton, Temet M McMichael, Adam D Kenney, Lizhi Zhang, Victoria Soewarna, Matthew Davis, Olivier Schwartz, Jacob S Yount. EMBO Rep 2017
53
23

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.
Jingyou Yu, Minghua Li, Jordan Wilkins, Shilei Ding, Talia H Swartz, Anthony M Esposito, Yi-Min Zheng, Eric O Freed, Chen Liang, Benjamin K Chen,[...]. Cell Rep 2015
104
23

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
Toshana L Foster, Harry Wilson, Shilpa S Iyer, Karen Coss, Katie Doores, Sarah Smith, Paul Kellam, Andrés Finzi, Persephone Borrow, Beatrice H Hahn,[...]. Cell Host Microbe 2016
109
23

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.
Thérèse Couderc, Fabrice Chrétien, Clémentine Schilte, Olivier Disson, Madly Brigitte, Florence Guivel-Benhassine, Yasmina Touret, Georges Barau, Nadège Cayet, Isabelle Schuffenecker,[...]. PLoS Pathog 2008
388
21

Interferon-induced transmembrane protein 3 is a type II transmembrane protein.
Charles C Bailey, Hema R Kondur, I-Chueh Huang, Michael Farzan. J Biol Chem 2013
62
21

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Kevin Tartour, Romain Appourchaux, Julien Gaillard, Xuan-Nhi Nguyen, Stéphanie Durand, Jocelyn Turpin, Elodie Beaumont, Emmanuelle Roch, Gregory Berger, Renaud Mahieux,[...]. Retrovirology 2014
87
21

Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.
Nicholas M Chesarino, Temet M McMichael, Jacob S Yount. Future Microbiol 2014
44
22

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.
Jessica M Weidner, Dong Jiang, Xiao-Ben Pan, Jinhong Chang, Timothy M Block, Ju-Tao Guo. J Virol 2010
221
21

Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry.
Amanda A Anafu, Christopher H Bowen, Christopher R Chin, Abraham L Brass, Geoffrey H Holm. J Biol Chem 2013
77
21


IFITM3 directly engages and shuttles incoming virus particles to lysosomes.
Jennifer S Spence, Ruina He, Hans-Heinrich Hoffmann, Tandrila Das, Emmanuelle Thinon, Charles M Rice, Tao Peng, Kartik Chandran, Howard C Hang. Nat Chem Biol 2019
102
21

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.
Clémentine Schilte, Thérèse Couderc, Fabrice Chretien, Marion Sourisseau, Nicolas Gangneux, Florence Guivel-Benhassine, Anton Kraxner, Jürg Tschopp, Stephen Higgs, Alain Michault,[...]. J Exp Med 2010
198
19


Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor.
Angela Chow, Zhisheng Her, Edward K S Ong, Jin-miao Chen, Frederico Dimatatac, Dyan J C Kwek, Timothy Barkham, Henry Yang, Laurent Rénia, Yee-Sin Leo,[...]. J Infect Dis 2011
221
19

The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus.
Cody J Warren, Laura M Griffin, Alexander S Little, I-Chueh Huang, Michael Farzan, Dohun Pyeon. PLoS One 2014
53
19

Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model.
Aaron R Everitt, Simon Clare, Jacqueline U McDonald, Leanne Kane, Katherine Harcourt, Malika Ahras, Amar Lall, Christine Hale, Angela Rodgers, Douglas B Young,[...]. PLoS One 2013
47
19

Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection.
Zhongfang Wang, Anli Zhang, Yanmin Wan, Xinian Liu, Chao Qiu, Xiuhong Xi, Yanqin Ren, Jing Wang, Yuan Dong, Meijuan Bao,[...]. Proc Natl Acad Sci U S A 2014
193
19

Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses.
Florian Wrensch, Christina B Karsten, Kerstin Gnirß, Markus Hoffmann, Kai Lu, Ayato Takada, Michael Winkler, Graham Simmons, Stefan Pöhlmann. J Infect Dis 2015
39
23

Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates.
Zhao Zhang, Jun Liu, Meng Li, Hui Yang, Chiyu Zhang. PLoS One 2012
57
19

IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.
Rajini Mudhasani, Julie P Tran, Cary Retterer, Sheli R Radoshitzky, Krishna P Kota, Louis A Altamura, Jeffrey M Smith, Beverly Z Packard, Jens H Kuhn, Julie Costantino,[...]. J Virol 2013
86
19

Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Xuesen Zhao, Mohit Sehgal, Zhifei Hou, Junjun Cheng, Sainan Shu, Shuo Wu, Fang Guo, Sylvain J Le Marchand, Hanxin Lin, Jinhong Chang,[...]. J Virol 2018
59
19

Chikungunya virus arthritis in adult wild-type mice.
Joy Gardner, Itaru Anraku, Thuy T Le, Thibaut Larcher, Lee Major, Pierre Roques, Wayne A Schroder, Stephen Higgs, Andreas Suhrbier. J Virol 2010
275
17

IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.
Lisa F P Ng, Angela Chow, Yong-Jiang Sun, Dyan J C Kwek, Poh-Lian Lim, Frederico Dimatatac, Lee-Ching Ng, Eng-Eong Ooi, Khar-Heng Choo, Zhisheng Her,[...]. PLoS One 2009
190
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.